>_ Why This Matters: Science is a living ecosystem
A genetic report is not simply a raw transcription of your DNA.
Report = Your Genetic Data + Current Evidence + Current Databases + Interpretation Rules
Imagine receiving a report in 2026 with an Emerging evidence rating. Five years later, thousands of additional participants have been studied, three independent cohorts replicate the association, and a functional experiment confirms the mechanism.
Your genotype did not change. The scientific confidence around its interpretation did.
>_ How Often Does Reclassification Happen?
A major 2024 JAMA Network Open study examined data from more than 3.2 million individuals undergoing clinical genetic testing between 2015 and 2023.
Most reclassifications resolved variants of uncertain significance (VUS) into more definitive categories. True reversals from benign to pathogenic were rare.
>_ Clinical ACMG/AMP Classification Spectrum
For germline variants, clinical laboratories follow the standardized 5-category ACMG/AMP framework:
>_ What GENOSTRIDE Preserves: Versioned Provenance
To maintain complete scientific integrity, every report should preserve a versioned provenance card:
Evidence reviewed: August 2026
Reference Genome: GRCh38.p14
ClinVar Assertion: Review status ⭐⭐⭐ (Expert Panel)
Classification: Moderate (Updated from Emerging)
Reason for Update: 2026 multi-cohort meta-analysis replication